, Volume 30, Issue 2, pp 147–170 | Cite as

Osteoporotic Fractures

A Systematic Review of US Healthcare Costs and Resource Utilization
  • Sangeeta Budhia
  • Yeshi Mikyas
  • Michael Tang
  • Enkhe Badamgarav
Review Article Cost and Resource Use of Osteoporotic Fractures in the US


Osteoporotic fractures are costly in terms of both the dollar amount and healthcare utilization. The objective of this review was to systematically synthesize published evidence regarding direct costs associated with the treatment of osteoporosis-related fractures in the US.

We conducted a systematic literature review of published studies that used claims databases and economic studies reporting costs associated with osteoporosis-related fractures in the US. Studies published between 1990 and 2011 were systematically searched in PubMed (primary source), Ovid HealthSTAR, EMBASE and the websites of large agencies. Data concerning study design, patient population and cost components assessed were extracted with qualitative assessment of studymethods, limitations and conclusions. Cost assessment included direct medical and hospitalization (inpatient) costs. The cost differences by age and gender were examined.

Of the 33 included studies, 26 reported an estimated total medical cost and hospital resource use associated with osteoporotic fractures. These studies indicated that, in the year following a fracture, medical and hospitalization costs were 1.6–6.2 higher than pre-fracture costs and 2.2–3.5 times higher than those for matched controls. Analysis of the hospitalization costs by osteoporotic fracture type resulted in hip fractures identified as the most expensive fracture type (unit cost range $US8358–32 195), while wrist and forearm fractures were the least expensive (unit cost range $US1885–12 136). Although incremental fracture costs were generally lower in the elderly than in the younger population, total costs were highest for the older (≥65 years of age) population. Total healthcare costs for fractures were highest for the older female population, but unit fracture costs in women were not consistently found to be higher than for men. The qualitative assessment of the included studies demonstrated that the design and reporting of individual studies were of good quality. However, the findings of this review and comparisons across studies were limited by differences in methodologies used by the different studies to derive costs, the populations included in the studies used and the fracture assessment.

Despite the variability in estimates, the literature indicates that osteoporosisrelated fractures are associated with high total medical and hospitalization costs in the US. The variability in the cost estimates highlights the importance of comparing the methodologies and the types of costs used when choosing an appropriate unit cost for economic modelling.



Funding for this study was provided by Amgen Inc. The services of Heron Evidence Development Ltd were retained by Amgen Inc. for this project. S. Budhia and M. Tang are employed by Heron Evidence Development Ltd. E. Badamgarav and Y. Mikyas are employed by Amgen Inc. All authors contributed equally in the research development of this article. Editorial support was provided by S. Stoddart (Heron Evidence Development Ltd).


  1. 1.
    NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention,diagnosis, and therapy. JAMA 2001; 285 (6): 785–95CrossRefGoogle Scholar
  2. 2.
    National Osteoporosis Foundation. Prevalence report [online]. Available from URL: [Accessed 2010 May 17]Google Scholar
  3. 3.
    Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002; 359 (9319): 1761–7PubMedCrossRefGoogle Scholar
  4. 4.
    Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17 (12): 1726–33PubMedCrossRefGoogle Scholar
  5. 5.
    United States Bone and Joint Decade. The burden of musculoskeletal diseases in the United States: prevalence, societal and economic cost. Rosemont (IL): USBJD, 2008 [online]. Available from URL: [Accessed 2010 Jun 4]Google Scholar
  6. 6.
    Office of the Surgeon General. Bone health and osteoporosis: a report of the Surgeon General. Rockville (MD): U.S. Department of Health and Human Services, 2004 [online]. Available from URL: [Accessed 2010 Jun 3]Google Scholar
  7. 7.
    He W, Sengupta M, Velkoff VA, et al. 65+ in the United States: 2005. Current population reports, special studies [report no. P23-209]. Washington, DC: U.S. Department of Health and Human Services, U.S. Department of Commerce, 2005 Dec [online]. Available from URL: [Accessed 2010 Jun 3]Google Scholar
  8. 8.
    Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007; 22 (3): 465–75PubMedCrossRefGoogle Scholar
  9. 9.
    Drummond MF, Sculpher MJ, Torrance GW, et al. Critical assessment of economic evaluation. In: Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005: 27–53Google Scholar
  10. 10.
    Centers for Disease Control and Prevention. Incidence and costs to Medicare of fractures among Medicare beneficiaries aged > or = 65 years: United States, July 1991-June 1992. MMWR Morb Mortal Wkly Rep 1996; 45 (41): 877–83Google Scholar
  11. 11.
    Bass E, French DD, Bradham DD. A national perspective of Medicare expenditures for elderly veterans with hip fractures. J Am Med Dir Assoc 2008; 9 (2): 114–9PubMedCrossRefGoogle Scholar
  12. 12.
    Beck TS, Brinker MR, Daum WJ. In-hospital charges associated with the treatment of adult femoral neck fractures. Am J Orthop (Belle Mead NJ) 1996; 25 (9): 608–12Google Scholar
  13. 13.
    Brainsky A, Glick H, Lydick E, et al. The economic cost of hip fractures in community-dwelling older adults: a prospective study. J Am Geriatr Soc 1997; 45 (3): 281–7PubMedGoogle Scholar
  14. 14.
    Burge R, Puleo E, Gehlbach S, et al. Inpatient hospital and post-acute care for vertebral fractures in women. Value Health 2002; 5 (4): 301–11PubMedCrossRefGoogle Scholar
  15. 15.
    Burge RT, King AB, Balda E, et al. Methodology for estimating current and future burden of osteoporosis in state populations: application to Florida in 2000 through 2025. Value Health 2003; 6 (5): 574–83PubMedCrossRefGoogle Scholar
  16. 16.
    Christensen L, Iqbal S, Macarios D, et al. Cost of fractures commonly associated with osteoporosis in a managed-care population. J Med Econ 2010; 13 (2): 302–13PubMedCrossRefGoogle Scholar
  17. 17.
    Desai SS, Duncan BS, Sloan AS. The cost of treating osteoporosis in a managed health care organization. J Manag Care Pharm 2003; 9 (2): 142–9PubMedGoogle Scholar
  18. 18.
    Gabriel SE, Tosteson AN, Leibson CL, et al. Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002; 13 (4): 323–30PubMedCrossRefGoogle Scholar
  19. 19.
    Gehlbach SH, Avrunin JS, Puleo E. Trends in hospital care for hip fractures. Osteoporos Int 2007; 18 (5): 585–91PubMedCrossRefGoogle Scholar
  20. 20.
    Gehlbach SH, Burge RT, Puleo E, et al. Hospital care of osteoporosis-related vertebral fractures. Osteoporos Int 2003; 14 (1): 53–60PubMedCrossRefGoogle Scholar
  21. 21.
    Hoerger TJ, Downs KE, Lakshmanan MC, et al. Healthcare use among U.S. women aged 45 and older: total costs and costs for selected postmenopausal health risks. J Womens Health Gend Based Med 1999; 8 (8): 1077–89PubMedCrossRefGoogle Scholar
  22. 22.
    Kilgore ML, Morrisey MA, Becker DJ, et al. Health care expenditures associated with skeletal fractures among Medicare beneficiaries, 1999-2005. J Bone Miner Res 2009; 24 (12): 2050–5PubMedCrossRefGoogle Scholar
  23. 23.
    King AB, Tosteson AN, Wong JB, et al. Interstate variation in the burden of fragility fractures. J Bone Miner Res 2009; 24 (4): 681–92PubMedCrossRefGoogle Scholar
  24. 24.
    Lad SP, Patil CG, Lad EM, et al. Trends in pathological vertebral fractures in the United States: 1993 to 2004. J Neurosurg Spine 2007; 7 (3): 305–10PubMedCrossRefGoogle Scholar
  25. 25.
    Max W, Sinnot P, Kao C, et al. The burden of osteoporosis in California, 1998. Osteoporos Int 2002; 13 (6): 493–500PubMedCrossRefGoogle Scholar
  26. 26.
    Melton 3rd LJ, Gabriel SE, Crowson CS, et al. Costequivalence of different osteoporotic fractures. Osteoporos Int 2003; 14 (5): 383–8PubMedCrossRefGoogle Scholar
  27. 27.
    Ohsfeldt RL, Borisov NN, Sheer RL. Fragility fracturerelated direct medical costs in the first year following a nonvertebral fracture in a managed care setting. Osteoporos Int 2006; 17 (2): 252–8PubMedCrossRefGoogle Scholar
  28. 28.
    Orsini LS, Rousculp MD, Long SR, et al. Health care utilization and expenditures in the United States: a study of osteoporosis-related fractures. Osteoporos Int 2005; 16 (4): 359–71PubMedCrossRefGoogle Scholar
  29. 29.
    Pfister AK, Sale WG, Shaukat S. The economics of fragility fractures in West Virginia. W V Med J 2009; 105 (4): 10–3PubMedGoogle Scholar
  30. 30.
    Pike C, Birnbaum HG, Schiller M, et al. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US. Pharmacoeconomics 2010; 28 (5): 395–409PubMedCrossRefGoogle Scholar
  31. 31.
    Pike C, Birnbaum HG, Schiller M, et al. Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US. Osteoporos Int 2011; 22 (1): 47–56PubMedCrossRefGoogle Scholar
  32. 32.
    Ray NF, Chan JK, Thamer M, et al. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12 (1): 24–35PubMedCrossRefGoogle Scholar
  33. 33.
    Rousculp MD, Long SR, Wang S, et al. Economic burden of osteoporosis-related fractures in Medicaid. Value Health 2007; 10 (2): 144–52PubMedCrossRefGoogle Scholar
  34. 34.
    Russo A, Holmquist L, Elixhauser A. U.S. hospitalizations involving osteoporosis and injury, 2006 [report no. 76]. Rockville (MD): Agency for Healthcare Research and Quality, 2009 [online]. Available from URL: [Accessed 2010 Jun 3]Google Scholar
  35. 35.
    Sasser AC, Rousculp MD, Birnbaum HG, et al. Economic burden of osteoporosis, breast cancer, and cardiovascular disease among postmenopausal women in an employed population. Womens Health Issues 2005; 15 (3): 97–108PubMedCrossRefGoogle Scholar
  36. 36.
    Shi N, Foley K, Lenhart G, et al. Direct healthcare costs of hip, vertebral, and non-hip, non-vertebral fractures. Bone 2009; 45 (6): 1084–90PubMedCrossRefGoogle Scholar
  37. 37.
    Blume SW, Curtis JR. Medical costs of osteoporosis in the elderly Medicare population. Osteoporos Int 2011; 22 (6): 1835–44PubMedCrossRefGoogle Scholar
  38. 38.
    Romley JA, Jena AB, Goldman DP. Hospital spending and inpatient mortality – evidence from California: an observational study. Ann Intern Med 2011; 154 (3): 160–7PubMedGoogle Scholar
  39. 39.
    Shauver MJ, Yin H, Banerjee M, et al. Current and future national costs to Medicare for the treatment of distal radius fracture in the elderly. J Hand Surg Am 2011; 36 (8): 1282–7PubMedCrossRefGoogle Scholar
  40. 40.
    Song X, Shi N, Badamgarav E, et al. Cost burden of second fracture in the US health system. Bone 2011; 48 (4): 828–36PubMedCrossRefGoogle Scholar
  41. 41.
    Buntin MB, Colla CH, Deb P, et al. Medicare spending and outcomes after postacute care for stroke and hip fracture. Med Care 2010; 48 (9): 776–84PubMedCrossRefGoogle Scholar
  42. 42.
    Colon-Emeric C, Kuchibhatla M, Pieper C, et al. The contribution of hip fracture to risk of subsequent fractures: data from two longitudinal studies. Osteoporos Int 2003; 14 (11): 879–83PubMedCrossRefGoogle Scholar
  43. 43.
    Ojo F, Al SS, Ray LA, et al. History of fractures as predictor of subsequent hip and nonhip fractures among older Mexican Americans. J Natl Med Assoc 2007; 99 (4): 412–8PubMedGoogle Scholar
  44. 44.
    Lindsay R, Burge RT, Strauss DM. One year outcomes and costs following a vertebral fracture. Osteoporos Int 2005; 16 (1): 78–85PubMedCrossRefGoogle Scholar
  45. 45.
    Marks R. Hip fracture epidemiological trends, outcomes, and risk factors, 1970-2009. Int J Gen Med 2010; 3: 1–17PubMedGoogle Scholar
  46. 46.
    Becker DJ, Yun H, Kilgore ML, et al. Health services utilization after fractures: evidence from Medicare. J Gerontol A Biol Sci Med Sci 2010; 65 (9): 1012–20PubMedCrossRefGoogle Scholar
  47. 47.
    Bergstrom U, Jonsson H, Gustafson Y, et al. The hip fracture incidence curve is shifting to the right. Acta Orthop 2009; 80 (5): 520–4PubMedCrossRefGoogle Scholar
  48. 48.
    Piscitelli P, Gimigliano F, Gatto S, et al. Hip fractures in Italy: 2000-2005 extension study. Osteoporos Int 2010; 21 (8): 1323–30PubMedCrossRefGoogle Scholar
  49. 49.
    Pentek M, Horvath C, Boncz I, et al. Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos Int 2008; 19 (2): 243–9PubMedCrossRefGoogle Scholar
  50. 50.
    Curran D, Maravic M, Kiefer P, et al. Epidemiology of osteoporosis-related fractures in France: a literature review. Joint Bone Spine 2010; 77 (6): 546–51PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2012

Authors and Affiliations

  • Sangeeta Budhia
    • 1
  • Yeshi Mikyas
    • 2
  • Michael Tang
    • 1
  • Enkhe Badamgarav
    • 2
  1. 1.Heron Evidence Development LtdStopsleyUK
  2. 2.Amgen Inc.Thousand OaksUSA

Personalised recommendations